Sweden has demonstrated that a single gene therapy injection can restore hearing in people born with a genetic form of deafness, offering a potential long-term treatment.
Landmark gene editing therapy for sickle cell disease patients will soon be available to people with severe forms of the illness across the United Kingdom.
